Recent advancements in oncology are fundamentally shifting the paradigm of cancer treatment, emphasizing long-term management and sustained quality of life for patients. This focus was highlighted by Ilir Kurtishi, an oncologist and Director of the Oncology Clinic, during an appearance on the podcast “Health First,” which was supported by United Hospital. During the discussion, Dr.
Kurtishi detailed the latest breakthroughs in treating malignant diseases and the integration of modern therapeutic approaches. According to the oncologist, the primary objective of contemporary medicine is evolving toward managing certain forms of cancer much like chronic conditions, such as diabetes or hypertension. This represents a significant departure from older models of treatment.
Dr. Kurtishi elaborated that the goal is to optimize outcomes regardless of the disease stage. For early-stage diagnoses, the focus remains on providing the best possible treatment to eliminate the threat.
However, when dealing with advanced cases, the objective shifts toward achieving durable control, allowing patients to continue to live with the best possible quality of life. This transition reflects a commitment to making cancer a manageable condition rather than solely an acute crisis. The incorporation of novel therapies allows medical professionals to work proactively with patients, aiming for sustained remission and improved longevity.
Experts suggest that this nuanced, chronic-care approach is crucial for improving patient outcomes and enhancing the ability of individuals to live full, productive lives despite a diagnosis of cancer.
Topics: #live #cancer #oncologist
It’s encouraging to hear the focus is shifting toward long-term management rather than just aggressive treatment.
What specific advancements are leading to a potential shift in cancer management towards a chronic care model similar to diabetes?